Mackenzie Houin, PA
Physician Assistant · New Orleans, LANPI 1437667169
Payments from drug & device makers
Across 24 payments — averaging $143.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$175
- ADC Therapeutics America, Inc.$129
- Gilead$116
- Incyte Corporation$100
- CSL Behring$97
- plus $426 from 8 others
What the payments were for
- Consulting fees$1,67549%
- Travel & lodging$55716%
- Food & beverage$1,11032%
- Education$1003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $2,399 |
| AstraZeneca | 1 | $175 |
| ADC Therapeutics America, Inc. | 1 | $129 |
| Gilead | 1 | $116 |
| Incyte Corporation | 1 | $100 |
| CSL Behring | 1 | $97 |
| Bristol Myers Squibb | 1 | $87 |
| Ipsen Biopharmaceuticals, Inc | 1 | $77 |
| Johnson & Johnson | 2 | $67 |
| Legend Biotech USA Inc. | 3 | $65 |
| Janssen Scientific Affairs, LLC | 1 | $64 |
| Novartis | 1 | $34 |
| Beigene USA, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,443 in reported general payments places this provider in the 85th percentile of 1,246 physician assistant providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $22,776 |
| Acyclovir | 73 | $1,086 |
| Fluconazole | 11 | $358 |
| Allopurinol | 36 | $312 |
| Ondansetron OdtOndansetron | 16 | $300 |
| Promethazine Hcl | 15 | $275 |
| Prochlorperazine Maleate | 21 | $209 |
| Gabapentin | 21 | $208 |
| Oxycodone Hcl | 30 | $144 |
| Tramadol Hcl | 15 | $122 |
| Ondansetron Hcl | 14 | $97 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $88 |
| Prednisone | 19 | $45 |
| Olanzapine | 11 | $43 |
| Amlodipine Besylate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in New Orleans
- Jefferson OberleNew Orleans$66K
- Jennifer ScheuermannNew Orleans$56K
- Elizabeth ClementNew Orleans$35K
- David GsellNew Orleans$26K
- Nakia BrooksNew Orleans$25K
- Sydney TsenNew Orleans$16K
- Stephanie EscheteNew Orleans$9K
- Rija AmirNew Orleans$7K
- Emily EstopinalNew Orleans$6K
- Shelly EsnardBaton Rouge$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.